`
Thursday, 17 August 2017

Drug Discovery News

  • PeptiDream, Teijin to co-discover peptide-based therapeutics

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2015

    Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization collaboration agreement with Teijin Pharma Limited, Tokyo, Japan. The ...Read more

  • 3SBio, Alteogen to develop antibody for metastatic cancer

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 13 Oct, 2015

    Singapore: 3SBio, China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, has entered into an exclusive licensing deal ...Read more

  • Roivant acquires GSK's Alzheimer's drug candidate

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 30 Dec, 2014

    Singapore: US based Roivant Neurosciences, a biopharmaceutical company engaged in the development and commercialization of late-stage drug candidates for neurologic diseases, has acquired G...Read more

  • Korea's ImmunoMet raises $5.2 mn

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2016

    Singapore: Korea based ImmunoMet Therapeutics, a biotechnology company developing innovative drugs for the treatment of cancer, has raised $5.2 million in a Series A financing led by Mirae ...Read more

  • Cellworks, AstraZeneca join hands for TB research

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2012

    Bangalore: AstraZeneca and Cellworks have announced a collaboration, to speed the design of novel combination therapies for the treatment of drug-sensitive and resistant tuberculosis. This ...Read more

  • Dengue can soon be treated!

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2015

    Singapore: Researchers from the University of Queensland in Australia have identified that existing drugs could be repurposed to create a world-first treatment for dengue fever. The team s...Read more

  • Genticel secures patent for a targeted therapy for cancer

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015

    Singapore: Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), has been granted a new p...Read more

  • Hong Kong approves asthma drug flutiform

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2013

    ‎Singapore: Mundipharma, an Asian pharmaceutical company, has launched Flutiform (fluticasone propionate/formoterol fumarate), a new combination therapy for the maintenance treatment ...Read more

  • FDA nod for Novartis eyecare firm's glaucoma drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 22 Apr, 2013

    Singapore: Alcon, the global leader in eye care and a division of Novartis, has recieved US FDA approval for Simbrinza suspension, indicated for the reduction of elevated intraocular pressu...Read more

  • FDA stamps Merck's Hep C drug as breakthough therapy

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2015

    Singapore: Merck's grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis C virus (HCV) infection, has received breakthrough therapy designati...Read more

  • Astellas, FibroGen start CKD anemia trial in Japan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013

    Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-4592 for the treatment of anemia associated with chronic kidney disea...Read more

  • Aussie firm to begin human trial of cancer detecting antibody

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2015

    Singapore: Australian immuno-oncology company, Minomic International, is set to launch the first human study of its novel monoclonal antibody technology as an imaging agent to detect prosta...Read more

  • USFDA approves 'Female Viagra'

    Drug Discovery |  News | By Raj Gunashekar | 0 Comment | 19 Aug, 2015

    US-based Sprout Pharmaceuticals gained USFDA's approval for Addyi, whose chemical name is Flibanserin, created to enhance sex drive in premenopausal women or women suffering from hypoactive...Read more

  • BioDiem protozoan drug to get Japanese patent

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013

    Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Japanese patent for its novel antimicrobial compound, BDM-I. The patent...Read more

  • Gilead submits NDA for cancer drug Idelalisib

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2013

    Singapore: Gilead Sciences has submitted a new drug application (NDA) to the US FDA for the approval of Idelalisib, an investigational, targeted, oral inhibitor of PI3K delta, for the treat...Read more

  • TWi's drug gets rare disease drug designation in Taiwan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2015

    Singapore: Taiwan based TWi Pharmaceutical's drug candidate AC-203 has received designation of rare disease drug by Taiwan FDA to treat Epidermolysis Bullosa Simplex (EBS), and is eligible ...Read more

  • Singapore scientists engineer human stem cells

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2013

    Singapore: A*Star's Genome Institute of Singapore (GIS) have successfully converted human embryonic stem cells (hESCs) cultured in the laboratory to a state that is closer to the cells foun...Read more

  • Aussie firm likely to get orphan status for its new drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015

    Singapore: Australia based Prana Biotechnology has recieved positive opinion from European Medicines Agency's Committee for Orphan Medicinal Products (COMP) for the designation of its drug ...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls